Home Authors Posts by Kaitlyn D’Onofrio

Kaitlyn D’Onofrio

1415 POSTS 0 COMMENTS
Kaitlyn D’Onofrio is a digital medical writer. She is interested in musculoskeletal health, the effect of exercise on health, and mental health awareness. When she’s not writing for DocWire, Kaitlyn is teaching yoga classes in her community, promoting wellness to her students.
FDA, Arthritis Medication Comparison, Expert Interviews: Rheum Round-up, PROs, Rheum Round-up: Abatacept vs. Other bDMARDs in RA, OA and Discrimination, and more

Rheum Round-up: Johnson & Johnson Vaccine Updates, Insights From Rheumatologists, and...

Here’s What Rheumatologists Have to Say About the Johnson & Johnson Vaccine

Here’s What Rheumatologists Have to Say About the Johnson & Johnson...

Study Asks ‘What Is Nursing Work?’—And It’s A Lot

Study Asks ‘What Is Nursing Work?’—And It’s A Lot

johnson, immunocompromised

FDA, CDC: Pause Johnson & Johnson Vax—What This Means for Immunocompromised...

Aprepitant Effective in Reducing Nausea from Chemo in Women,Maximizing Use of Health Systems Vital in Improving Cancer Outcomes

Aprepitant Effective in Reducing Nausea from Chemo in Women

oklahoma, hydroxychloroquine, rheumatologist, rheumatologists

Hydroxychloroquine Improves Vascular Outcomes in Patients with Systemic Lupus Erythematosus

Psoriasis, psoriatic, hydroxychloroquine, RA, ACR, vitamin, vitamins, Rheum Round-up: Interviews with Authors of ‘Untold Stories’ of Female Surgeons, and more

Rheum Round-up: Why Psoriasis Pts May Take MTX Break After J&J...

What Factors Prevent Advanced Care Planning for Parents of Pediatric Patients?

What Factors Prevent Advanced Care Planning for Parents of Pediatric Patients?

Abstract Perspective: Impact of assessing patient-reported outcomes with mobile apps on...

Tofacitinib Under Review for Heart-related Issues, Cancer in Canada Months after FDA Announcement

Tofacitinib Under Review for Heart-related Issues, Cancer in Canada Months after...

123...142Page 1 of 142